These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 33192503)

  • 1. Systematic Review and Pharmacological Considerations for Chloroquine and Its Analogs in the Treatment for COVID-19.
    Peng H; Chen Z; Wang Y; Ren S; Xu T; Lai X; Wen J; Zhao M; Zeng C; Du L; Zhang Y; Cao L; Hu J; Wei X; Hong T
    Front Pharmacol; 2020; 11():554172. PubMed ID: 33192503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.
    de Barros CM; Almeida CAF; Pereira B; Costa KCM; Pinheiro FA; Maia LDB; Trindade CM; Garcia RCT; Torres LH; Diwan S; Boralli VB
    Pain Physician; 2020 Aug; 23(4S):S351-S366. PubMed ID: 32942793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story.
    Gasmi A; Peana M; Noor S; Lysiuk R; Menzel A; Gasmi Benahmed A; Bjørklund G
    Appl Microbiol Biotechnol; 2021 Feb; 105(4):1333-1343. PubMed ID: 33515285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19.
    Ho TC; Wang YH; Chen YL; Tsai WC; Lee CH; Chuang KP; Chen YA; Yuan CH; Ho SY; Yang MH; Tyan YC
    Pathogens; 2021 Feb; 10(2):. PubMed ID: 33671315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19).
    Shah S; Das S; Jain A; Misra DP; Negi VS
    Int J Rheum Dis; 2020 May; 23(5):613-619. PubMed ID: 32281213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.
    Rainsford KD; Parke AL; Clifford-Rashotte M; Kean WF
    Inflammopharmacology; 2015 Oct; 23(5):231-69. PubMed ID: 26246395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review.
    Rodrigo C; Fernando SD; Rajapakse S
    Clin Microbiol Infect; 2020 Aug; 26(8):979-987. PubMed ID: 32470568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of chloroquine and hydroxychloroquine in the treatment of patients with COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis.
    Liu Y; Fu X; Xie C
    Medicine (Baltimore); 2020 Sep; 99(37):e22031. PubMed ID: 32925737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review on possible modes of action of chloroquine/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic.
    Tripathy S; Dassarma B; Roy S; Chabalala H; Matsabisa MG
    Int J Antimicrob Agents; 2020 Aug; 56(2):106028. PubMed ID: 32450198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chloroquine and hydroxychloroquine provoke arrhythmias at concentrations higher than those clinically used to treat COVID-19: A simulation study.
    Okada JI; Yoshinaga T; Washio T; Sawada K; Sugiura S; Hisada T
    Clin Transl Sci; 2021 May; 14(3):1092-1100. PubMed ID: 33404133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of Hydroxychloroquine Cardiotoxicity: Lessons From the COVID-19 Pandemic.
    Gagnon LR; Sadasivan C; Yogasundaram H; Oudit GY
    Curr Heart Fail Rep; 2022 Dec; 19(6):458-466. PubMed ID: 36167917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review on the pharmacokinetic properties and toxicity considerations for chloroquine and hydroxychloroquine to potentially treat coronavirus patients.
    Askarian F; Firoozi Z; Ebadollahi-Natanzi A; Bahrami S; Rahimi HR
    Toxicol Res; 2022 Apr; 38(2):137-148. PubMed ID: 34306523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19?
    Derwand R; Scholz M
    Med Hypotheses; 2020 Sep; 142():109815. PubMed ID: 32408070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chloroquine and hydroxychloroquine ototoxicity; potential implications for SARS-CoV-2 treatment. A brief review of the literature.
    De Luca P; Scarpa A; De Bonis E; Cavaliere M; Viola P; Gioacchini FM; Ralli M; Ettore C; Claudia C
    Am J Otolaryngol; 2021; 42(5):102640. PubMed ID: 33780902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxychloroquine/chloroquine in patients with COVID-19 in Wuhan, China: a retrospective cohort study.
    Chen Z; Liu A; Cheng Y; Wang X; Xu X; Huang J; Ma Y; Gao M; Huang C
    BMC Infect Dis; 2021 Aug; 21(1):805. PubMed ID: 34384388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research Progress of Chloroquine and Hydroxychloroquine on the COVID-19 and Their Potential Risks in Clinic Use.
    Chen Y; Shen T; Zhong L; Liu Z; Dong X; Huang T; Wang Q; Xiao H
    Front Pharmacol; 2020; 11():1167. PubMed ID: 32848774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chloroquine and Hydroxychloroquine for the Prevention and Treatment of COVID-19: A Fiction, Hope or Hype? An Updated Review.
    Saghir SAM; AlGabri NA; Alagawany MM; Attia YA; Alyileili SR; Elnesr SS; Shafi ME; Al-Shargi OYA; Al-Balagi N; Alwajeeh AS; Alsalahi OSA; Patra AK; Khafaga AF; Negida A; Noreldin A; Al-Amarat W; Almaiman AA; El-Tarabily KA; Abd El-Hack ME
    Ther Clin Risk Manag; 2021; 17():371-387. PubMed ID: 33953559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chloroquine, hydroxychloroquine, and COVID-19: Systematic review and narrative synthesis of efficacy and safety.
    Takla M; Jeevaratnam K
    Saudi Pharm J; 2020 Dec; 28(12):1760-1776. PubMed ID: 33204210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chloroquine and hydroxychloroquine as a repurposed agent against COVID-19: a narrative review.
    Acharya Y; Sayed A
    Ther Adv Infect Dis; 2020; 7():2049936120947517. PubMed ID: 32821381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection.
    Klimke A; Hefner G; Will B; Voss U
    Med Hypotheses; 2020 Sep; 142():109783. PubMed ID: 32402766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.